Kostas Research Center for Cardiovascular Nanomedicine: “The New Frontier of RNA Nanotherapeutics”
The RNA vaccines against COVID-19 mark the beginning of a technological revolution that will transform the way we treat disease and restore health. “The New Frontier of RNA Nanotherapeutics” meeting presented by the George and Angelina Kostas Research Center for Cardiovascular Nanomedicine, will feature a discussion on the events that led to the RNA vaccine breakthrough and preview emerging RNA Nanotherapeutics. Advances in the design of RNA constructs to improve stability and translational efficiency, will be presented along with the leading-edge developments in nanomedicine to improve delivery and tissue specificity. The potential of nanotechnology-enabled RNA therapeutics to enhance health is virtually limitless.
CALL FOR POSTERS
Poster abstracts are being solicited that address challenges in the field of cardiovascular nanomedicine. Prizes for the best poster presentations will be awarded at the Annual International Meeting. For guidelines and eligibility information, visit: https://learn.houstonmethodist.org/content/call-for-posters
TARGET AUDIENCE
Physicians, scientists, nurses, researchers, residents/fellows, other health care professionals (surgery, cardiovascular, nanomedicine) will benefit from this course.